Gemstone Biotherapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 9

Gemstone Biotherapeutics General Information

Description

Developer of scar-free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surgery, and burn care. The company's technology offer products that accelerate healing, avoid complex closure, and regenerate skin without scarring after burns or excisions, thereby enabling patients to heal wounds.

Contact Information

Formerly Known As
Chiron Labs, Hydro3Labs, Gemstone Therapeutics
Ownership Status
Out of Business
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 180 West Ostend Street
  • Suite 277A
  • Baltimore, MD 21230
  • United States
+1 (443) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemstone Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 00.000 Completed Out of Business
7. Later Stage VC 28-Aug-2019 00000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2019 000 Completed Generating Revenue
5. Grant 22-Jun-2018 00000 000 Completed Generating Revenue
4. Early Stage VC 27-Oct-2016 00000 000 Completed Generating Revenue
3. Seed Round 08-Jun-2015 00.000 00.00 Completed Generating Revenue
2. Accelerator/Incubator 05-Feb-2015 $850K $850K Completed Generating Revenue
1. Spin-Off 01-Jan-2013 Completed Startup
To view Gemstone Biotherapeutics’s complete valuation and funding history, request access »

Gemstone Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of scar-free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surg
Drug Discovery
Baltimore, MD
2 As of 2023
00.000
000 00 00000 00.000

00000ï

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000 000000000
Mont-Saint-Guibert, Belgium
00 As of 0000
00000
0000000000 0 00000

00000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
0000000000000
Memphis, TN
00 As of 0000
000.00
00000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gemstone Biotherapeutics Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellaïon Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 0000000000 0 00000
Triad Life Sciences Private Equity-Backed Memphis, TN 00 000.00 000000&0 000.00
PolarityTE Corporate Backed or Acquired Salt Lake City, UT 00 000.00 000000&0
IFM Therapeutics Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
Replicel Life Sciences Corporation Vancouver, Canada 0 000.00 000000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

Gemstone Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gemstone Biotherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The University System of Maryland Momentum Fund Venture Capital Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0
Maryland Stem Cell Research Fund Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Gemstone Biotherapeutics FAQs

  • When was Gemstone Biotherapeutics founded?

    Gemstone Biotherapeutics was founded in 2013.

  • Who is the founder of Gemstone Biotherapeutics?

    Sharon Gerecht Ph.D and George Davis are the founders of Gemstone Biotherapeutics.

  • Where is Gemstone Biotherapeutics headquartered?

    Gemstone Biotherapeutics is headquartered in Baltimore, MD.

  • What is the size of Gemstone Biotherapeutics?

    Gemstone Biotherapeutics has 2 total employees.

  • What industry is Gemstone Biotherapeutics in?

    Gemstone Biotherapeutics’s primary industry is Drug Discovery.

  • Is Gemstone Biotherapeutics a private or public company?

    Gemstone Biotherapeutics is a Private company.

  • What is Gemstone Biotherapeutics’s current revenue?

    The current revenue for Gemstone Biotherapeutics is 000000.

  • How much funding has Gemstone Biotherapeutics raised over time?

    Gemstone Biotherapeutics has raised $4.25M.

  • Who are Gemstone Biotherapeutics’s investors?

    The University System of Maryland Momentum Fund, Springboard Enterprises, Maryland Stem Cell Research Fund, National Science Foundation, and U.S. Department of Health and Human Services are 5 of 9 investors who have invested in Gemstone Biotherapeutics.

  • Who are Gemstone Biotherapeutics’s competitors?

    Cellaïon, Triad Life Sciences, PolarityTE, IFM Therapeutics, and Replicel Life Sciences are some of the 14 competitors of Gemstone Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »